AHPA’s 40th anniversary celebrations continue with our showcase of the eighth of many beloved herbs at the heart of our robust industry and vibrant community.
The American Herbal Products Association (AHPA) has offered feedback on mandatory product listing (MPL) provisions included in a recently released “discussion draft” of the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, a piece of must-pass legislation that reauthorizes drug and medical device user fee programs.
FDA has released a draft guidance outlining a proposed policy of enforcement discretion regarding the late submission of new dietary ingredient (NDI) notifications. Upon the release of a finalized guidance, companies will be able to electronically submit late NDIs to FDA for a set period (currently 180 days in the draft guidance) without penalty.
The American Herbal Products Association (AHPA) has estimated the dietary supplement industry will need to spend nearly 20 million dollars for initial compliance with the Dietary Supplement Listing Act, a bill introduced by Senators Richard Durbin (D-IL) and Mike Braun (R-IN) that would establish a requirement for mandatory product listing (MPL) for all dietary supplements marketed in the United States.
The United States Senate Committee on Health, Education, Labor and Pensions (HELP) has released a “discussion draft” of the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, a piece of must-pass legislation that reauthorizes drug and medical device user fee programs.
AHPA’s 40th anniversary celebrations continue with our showcase of the seventh of many beloved herbs at the heart of our robust industry and vibrant community.
The May 2022 AHPA Report includes: A message from the new AHPA Board Chair, 40ᵗʰ Anniversary Guest Feature by Jane Hawley Stevens, upcoming AHPA webinars, 40 Herbs We Love; and more!
AHPA’s 40th anniversary celebrations continue with our showcase of the sixth of many beloved herbs at the heart of our robust industry and vibrant community.
2022 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.